Does WellCare Cover Rybelsus? Medicare Advantage Coverage Guide 2026
Seniors on Medicare Advantage on WellCare Medicare Advantage (managed by Centene Corporation) often ask whether the formulary covers Rybelsus (oral semaglutide). Here’s the overview: coverage varies by specific formulary placement and clinical criteria.
WellCare’s Formulary Position on Rybelsus
WellCare Medicare Advantage uses a prescription drug list that categorizes medications based on coverage level. For the 2026 plan year, Rybelsus is typically listed at Tier 4 (Non-preferred specialty) for typical WellCare plan variants.
Practical implications:
- Cost-sharing: significant cost-sharing depending on coverage phase
- Prior authorization: Yes — a PA request is needed
- Quantity limits: May apply — limited to FDA-recommended dosing
- Step therapy: Could demand trying first-line therapies first
In the donut hole phase, you’ll owe 25% of Rybelsus’s cost until reaching the catastrophic threshold.
Coverage for FDA-Approved vs. Off-Label Use
For type 2 diabetes (FDA-approved):
- WellCare typically will authorize Rybelsus for on-label use
- Required evidence: clinical records showing medical necessity
- Approval rates are higher when used on-label
For weight loss (where applicable):
- Original Medicare Part D excludes anti-obesity medications for weight loss alone
- That said: recent CMS guidance broadened formulary inclusion rules for weight management medications
- WellCare could provide additional drug benefits that extend to weight management medications — call Centene Corporation member services
How Much Does Rybelsus Cost With WellCare
Calculating your out-of-pocket cost for Rybelsus on WellCare involves which Part D coverage phase you’re in.
| Coverage Phase | Typical Cost |
|---|---|
| Initial Deductible ($590 in 2026) | 100% of cost: $900–$1,100/month |
| Initial Coverage | Tier 4/5 copay |
| Coverage Gap (Donut Hole) | Significant coinsurance |
| Catastrophic Coverage | 5% coinsurance or $4.50–$11.20 copay |
Starting in 2025, total OOP costs won’t exceed $2,000 — providing substantial relief to anyone taking Rybelsus.
Navigating the PA Process
- Ask for a tier exception — If tier placement is too high, the prescriber can request a coverage exception with supporting documentation
- Check manufacturer support — Novo Nordisk offers copay cards that may help with Part D costs (eligibility varies)
- Compare plans during open enrollment — Annual Enrollment Period (Oct 15–Dec 7) allows compare formularies
- Check Low-Income Subsidy eligibility — For qualifying individuals can qualify for Extra Help (Low-Income Subsidy) that slash drug costs